טוען...
The role of peptide receptor radionuclide therapy in advanced/metastatic thoracic neuroendocrine tumors
Bronchopulmonary (BP) neuroendocrine tumors (NETs) comprise a spectrum of tumors that develop from respiratory neuroendocrine cells and represent ~20% of all lung neoplasia and ~30% of all NETs. The only curative treatment is surgical resection. For well-differentiated forms (typical and atypical ca...
שמור ב:
| הוצא לאור ב: | J Thorac Dis |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
AME Publishing Company
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5690948/ https://ncbi.nlm.nih.gov/pubmed/29201454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.09.82 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|